Question 9 Sample Clauses

Question 9. The contract establishes a single fee dollar per hour for the CPFF Term CLINs and a single fee % for the CPFF completion CLINs for the life of the contract. Specifically concerning the fee dollar per hour amount: If there are significant variations in the labor mix of the task orders as compared to the labor mix from which the fee is calculated, this could introduce additional risk for the Offeror. Similarly, there is additional risk if task orders are not equally distributed across the period of performance. Would the government consider calculating the fee dollar per hour for each year of the contract instead of a single number for the entire period of performance? Answer 9: No, the Government is not making any changes to the fee calculation. The contract will have one fee dollar per hour for the CPFF Term CLINs and one fee percentage for the CPFF Completion CLINs.
AutoNDA by SimpleDocs
Question 9. What additional costs may be incurred by you or those you represent as a result of implementing the AIHTS requirements for manufacturers? (For example, include costs incurred in relation to the alteration of designs and instructions and provision of suitable identification). Please quantify additional costs in £ Question 10: What additional training costs may be incurred by you or those you represent as a result of implementing the AIHTS? Please quantify additional cost in £ Question 11: Which make and models of stoat trap and how many do you or those you represent use? Make and model Number used BMI Magnum 110 BMI Magnum 116 Conibear 110-2 Conibear 120-2 DOC 150 DOC 200 DOC 250 Xxxx XX I Xxxx XX II Xxxx XX III Xxxx MKIV Xxxx MKVI Xxxxxxxxxx A24 Imbra MKI Imbra MKII Xxxx Xxxxx Trap 2000 Xxxxx Trap 2500 Xxxxx Xxxxxx Solway MK4 Solway MK6 Springer No. 4 Springer No. 6 WCS Tube Trap Cage-trap Other (please specify) Other (please specify) Question 12: Roughly how many of each permitted target species do you catch using these traps in an average year? Please give the total number of permitted target species caught per make and model (not the number caught per individual trap). Make and model Stoat Weasel Grey Squirrel Mink Rabbit Rat Mouse Edible Dormouse Other BMI Magnum 110 BMI Magnum 116 Conibear 110-2 Conibear 120-2 DOC 150 DOC 200 DOC 250 Xxxx XX I Xxxx XX II Xxxx XX III Xxxx MKIV Xxxx MKVI Xxxxxxxxxx A24 Imbra MKI Imbra MKII Xxxx Xxxxx Trap 2000 Xxxxx Trap 2500 Make and model Stoat Weasel Grey Squirrel Mink Rabbit Rat Mouse Edible Dormouse Other Xxxxx Xxxxxx Solway MK4 Solway MK6 Springer No. 4 Springer No. 6 WCS Tube Trap Cage-trap Other (please specify) Other (please specify) Question 13: How often in years do you or those you represent replace a particular make and model of trap (how long is its working life)? Please do not include traps that YOU or those you represent have but no longer use. Make and model Working Life of Trap BMI Magnum 110 BMI Magnum 116 Conibear 110-2 Conibear 120-2 DOC 150 DOC 200 DOC 250 Xxxx XX I Xxxx XX II Xxxx XX III Xxxx MKIV Xxxx MKVI Xxxxxxxxxx A24 Imbra MKI Imbra MKII Xxxx Xxxxx Trap 2000 Xxxxx Trap 2500 Xxxxx Xxxxxx Solway MK4 Solway MK6 Springer No. 4 Springer No. 6 WCS Tube Trap Cage-trap Other (please specify) Other (please specify) The purpose of the following questions is to estimate the average numbers of animals (other than stoat – see Q12) listed on AIHTS that are trapped each year and identify the traps used. Tho...
Question 9. If you are affiliated with a broker-dealer, did you have any agreements or understandings, directly or indirectly, with any person to distribute the securities at the time that you purchased the securities? ANSWER: Yes No Please note that the Commission takes the position that if you are a broker-dealer, you are to be identified in the Registration Statement as an underwriter. In the “Plan of Distribution,” the Registration Statement will provide substantially as follows: “The selling stockholders and any broker-dealers, agents or underwriters that participate with the selling stockholders in the distribution of the issued and outstanding shares of common stock or the shares of stock issuable upon exercise of warrants may be deemed to be “underwriters” within the meaning of the Securities Act, in which event any commissions received by these broker-dealers, agents or underwriters and any profits realized by the selling stockholders on the resales of the securities may be deemed to be underwriting commissions or discounts under the Securities Act. If the selling stockholders are deemed to be underwriters, the selling stockholders may be subject to certain statutory and regulatory liabilities, including liabilities imposed pursuant to Sections 11, 12 and 17 of the Securities Act and Rule 10b-5 under the Exchange Act.” QUESTION 10: Are their specific individuals who have voting or investment control over the securities? ANSWER: Yes No If you answered “yes”, please list the names of such individuals: The answers to the foregoing questions are true and correct to the best of the undersigned’s knowledge, information and belief. The undersigned agrees to promptly notify the Company in writing in care of Chief Financial Officer, InSite Vision Incorporated, 000 Xxxxxxxx Xxxxxx, Xxxxxxx, Xxxxxxxxxx 00000 of (a) any transfer by you of your Units, (b) sales of common stock of the Company (giving the number of shares sold and the name of the broker-dealer used) and (c) any other changes in the answers to this questionnaire that should be made as a result of any material development occurring subsequent to the date hereof. Dated: , 2004.
Question 9. Who do you believe to be the Critics/Sceptics in relation to H2 Powered Transport and Why are they Critics/Sceptics? % of Responses Nominating Category as Sceptics/Critics of H2 (N=58) Government/Officials Current Energy Producers (Elect./Oil) Environmental Groups Other Alternative Energy Lobby Some OEM's/Lobby Scientists 0 25 30 In an effort to broaden the base of individuals interviewed, interviewees were asked to nominate others whom they saw as critics and sceptics of the use of H2 in transport. It was noteworthy that some of the individuals/organisations that were nominated, when interviewed, did not see themselves as either critics or sceptics and were surprised to hear they had been identified as such.

Related to Question 9

  • Questions All questions or concerns regarding this Invitation for Bids shall be submitted by email to Xxxxxxx.Xxxxxxx@xxxx.xxx, no later than 5:00 PM Thursday, May 26, 2022 to the attention of Xxxxxxx Xxxxxxx, Procurement Division, referencing the IFB number. TABLE OF CONTENTS DESCRIPTION PAGE SECTION 1: GENERAL TERMS AND CONDITIONS GENERAL TERMS AND CONDITIONS 3-19 SECTION 2: SPECIAL TERMS AND CONDITIONS SPECIAL TERMS AND CONDITIONS 20-31 SECTION 3: SPECIFICATIONS/SCOPE OF SERVICES SPECIFICATIONS/SCOPE OF SERVICES 32-36 SECTION 4: BID SUBMISSION REQUIREMENTS AND DOCUMENTATION - QUALIFICATION OF BIDDERS (BID PACKAGE REQUIREMENTS) - BID RESPONSE FORM - EMERGENCY CONTACTS - ACKNOWLEDGEMENT OF ADDENDA - AUTHORIZED SIGNATORIES/NEGOTIATORS - REFERENCE DOCUMENTATION FORM - DRUG-FREE WORKPLACE FORM - SCHEDULE OF SUBCONTRACTING FORM - CONFLICT/NON-CONFLICT OF INTEREST FORM - E-VERIFICATION CERTIFICATION - RELATIONSHIP DISCLOSURE FORM - RELATIONSHIP DISCLOSURE FORM - FREQUENTLY ASKED QUESTIONS (FAQ) - ORANGE COUNTY SPECIFIC PROJECT EXPENDITURE REPORT - EXPENDITURE REPORT- FREQUENTLY ASKED QUESTIONS (FAQ) - AGENT AUTHORIZATION FORM - LEASED EMPLOYEE AFFIDAVIT - INFORMATION FOR DETERMINING JOINT VENTURE ELIGIBILITY - CONTRACT - ATTACHMENT A - DIRECTIONS TO ORANGE COUNTY CONVENTION CENTER - ATTACHMENT B – PARKING PASS SECTION 1 GENERAL TERMS AND CONDITIONS

  • Challenge If Executive violates or challenges the enforceability of any provisions of the Restrictive Covenants or this Release, no further payments, rights or benefits under Section 5 of the Agreement will be due to Executive (except where such provision would be prohibited by applicable law, rule or regulation).

  • Dispute a. In the event of any dispute whatsoever in respect of the sale, the Purchaser hereby expressly agrees to resolve the same with the Assignee.

  • CONCERNING BNY 1. BNY shall not be liable for any costs, expenses, damages, liabilities or claims, including attorneys' and accountants' fees, sustained or incurred by, or asserted against, the Fund except to the extent the same arises out of the failure of BNY to exercise the care, prudence and diligence required by Section 2 of Article II hereof. In no event shall BNY be liable to the Fund, the Board, or any third party for special, indirect or consequential damages, or for lost profits or loss of business, arising in connection with this Agreement.

  • Independent Status The employees, volunteers, or agents of each party who are engaged in the performance of this Agreement will continue to be employees, volunteers, or agents of that party and will not for any purpose be employees, volunteers, or agents of the other party.

  • Shareholder Litigation The Company shall give Parent the opportunity to participate in the defense or settlement of any shareholder litigation against the Company and/or its directors relating to the transactions contemplated by this Agreement, and no such settlement shall be agreed to without Parent’s prior written consent.

  • Interpretation; Knowledge (a) When a reference is made in this Agreement to Exhibits, such reference shall be to an Exhibit to this Agreement unless otherwise indicated. When a reference is made in this Agreement to Sections, such reference shall be to a Section of this Agreement. Unless otherwise indicated the words "include," "includes" and "

  • Stockholder Litigation The Company shall give Parent the opportunity to participate in the defense or settlement of any stockholder litigation against the Company and/or its directors relating to the transactions contemplated by this Agreement, and no such settlement shall be agreed to without Parent’s prior written consent.

Time is Money Join Law Insider Premium to draft better contracts faster.